Iris Ngan

Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy

Yannan Xi, Benbo Song, Iris Ngan, Mark J. Solloway et autres

Type 1 diabetes mellitus (T1D) is a chronic disease with potentially severe complications, and β-cell deficiency underlies this disease. Despite active research, no therapy to date has been able to induce β-cell regeneration in humans. Here, we discover the β-cell regenerative effects …

us (code pays fourni par la source)

Publisher Correction: Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation

Jui–Hsia Weng, Peter David Koch, Harding H. Luan, Ho-Chou Tu et autres

us (code pays fourni par la source)

Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation

Jui–Hsia Weng, Peter David Koch, Harding H. Luan, Ho-Chou Tu et autres

us (code pays fourni par la source)

Glucagon Receptor Antagonism-Mediated β-Cell Regeneration as an Effective Anti-Diabetic Therapy

Yannan Xi, Benbo Song, Iris Ngan, Mark Humphrey et autres

us (code pays fourni par la source)

NGM621 is a Potent Inhibitory Anti-Complement C3 Antibody in Development for Treatment of Geographic Atrophy

Alexander Loktev, Iris Ngan, Kalyani Mondal, Yan Wang et autres

us (code pays fourni par la source)